Adagene Inc

Research Adagene Inc (ADAG) on Bullrun: market cap USD 199.37M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerADAG
• ExchangeNASDAQ
• CountryChina
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 199.37M
• Financial periodFY2025
• RevenueUSD 7.67M
• Revenue growth7332.8%
• Net income-USD 17.61M
• Free cash flow-USD 15.67M

Valuation Snapshot

latest market cap is USD 199.37M.

About Adagene Inc

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer.

Frequently asked questions

What is Adagene Inc's market cap?

Adagene Inc's market capitalization is USD 199.37M.

What does Adagene Inc do?

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China.